SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

Nature Neuroscience

Volumn 2, Issue 2, 1999, Pages 157-161

  Iadecola, Costantino ^a   Zhang, Fangyi ^a   Niwa, Kiyoshi ^a   Eckman, Chris ^b   Turner, Sherry K ^c   Fischer, Elizabeth ^d   Younkin, Steven ^b   Borchelt, David R ^e   Hsiao, Karen K ^a   Carlson, George A ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

^c MCLAUGHLIN RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; DEMENTIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; VASCULAR ENDOTHELIUM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HUMANS; MICE; MICE, TRANSGENIC; SUPEROXIDE DISMUTASE; VASOCONSTRICTOR AGENTS;

EID: 0033363939     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/5715     Document Type: Article

References (45)

1. Lendon, C. L., Ashall, F. & Goate, A. M. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277, 825-831 (1997).
2. Mattson, M. P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132 (1997).
3. Hensley, K. et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274 (1994).
4. Yan, S. D. et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
5. Behl, C., Davis, J. B., Lesley, R. & Schubert, D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827 (1994).
6. Thomas, T., Thomas, G., McLendon, C., Sutton, T. & Mullan, M. ß-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171 (1996).
7. Thomas, T., McLendon, C., Sutton, E. T. & Thomas, G. Cerebrovascular endothelial dysfunction mediated by beta-amyloid. Neuroreport 8, 1387-1391 (1997).
8. Crawford, F., Suo, Z., Fang, C. & Mullan, M. Characteristics of the in vitro vasoactivity of beta-amyloid peptides. Exp. Neurol. 150, 159-168 (1998).
9. Blanc, E. M., Toborek, M., Mark, R. J., Hennig, B. & Mattson, M. P. Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870-1881 (1997).
10. Hsiao, K. K. et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218 (1995).
11. Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116 (1995).
12. Sobey, C. G. & Faraci, F. M. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28, 837-843 (1997).
13. Rosenblum, W. I., McDonald, M. & Wormley, B. Calcium ionophore and acetylcholine dilate arterioles on the mouse brain by different mechanisms. Stroke 20, 1391-1395 (1989).
14. Rosenblum, W. I. Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke 17, 494-497 (1986).
15. Sobey, C. G., Heistad, D. D. & Faraci, F. M. Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels. Stroke 28, 2290-2294 (1997).
16. Mayhan, W. G. Role of activation of bradykinin B2 receptors in disruption of the blood-brain barrier during acute hypertension. Brain Res. 738, 337-341 (1996).
17. Rosenblum, W. I. & Nelson, G. H. Endothelium dependence of dilation of pial arterioles in mouse brain by calcium ionophore. Stroke 19, 1379-1382 (1988).
18. 2 in vivo. J. Cereb. Blood Flow Metab. 14, 944-951 (1994).
19. Faraci, F. M., Williams, J. K., Breese, K. R., Armstrong, M. L. & Heistad, D. D. Atherosclerosis potentiates constrictor responses of cerebral and ocular blood vessels to thromboxane in monkeys. Stroke 20, 242-247 (1989).
20. Mayhan, W. G., Faraci, F. M. & Heistad, D. D. Responses of cerebral arterioles to adenosine 5′-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension 12, 556-561 (1988).
21. Carlson, G. A. et al. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum. Mol. Genet. 6, 1951-1959 (1997).
22. Hsiao, K. et al. Correlative memory deficits, Aß elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
23. Stamler, J. S. A radical vascular connection. Nature 380, 108-111 (1996).
24. Mohazzab, K. M., Kaminski, P. M. & Wolin, M. S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266, H2568-2572 (1994).
25. Wang, P. et al. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc. Natl. Acad. Sci. USA 95, 4556-4560 (1998).
26. Yang, S. T., Mayhan, W. G., Faraci, F. M. & Heistad, D. D. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension 17, 612-618 (1991).
27. Wei, E. P., Kontos, H. A., Christman, C. W., DeWitt, D. S. & Povlishock, J. T. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ. Res. 57, 781-787 (1985).
28. Mayhan, W. G. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am. J. Physiol. 259, H1455-1462 (1990).
29. Sobey, C. G., Faraci, F. M., Piegors, D. J. & Heistad, D. D. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries. Stroke 27, 927-933 (1996).
30. Faraci, F. M. & Heistad, D. D. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol. Rev. 78, 53-97 (1998).
31. Zhang, F., Eckman, C., Younkin, S., Hsiao, K. K. & Iadecola, C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J. Neurosci. 17, 7655-7661 (1997).
32. Mentis, M. J. et al. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am. J. Psychiatry 153, 32-40 (1996).
33. Jagust, W. J., Eberling, J. L., Reed, B. R., Mathis, C. A. & Budinger, T. F. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann. NY Acad. Sci. 826, 254-262 (1997).
34. Hock, C. et al. Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS) - correlation with simultaneous rCBF-PET measurements. Brain Res. 755, 293-303 (1997).
35. Warkentin, S. & Passant, U. Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test. Dement. Geriatr. Cogn. Disord. 8, 105-109 (1997).
36. Hatake, K., Kakishita, E., Wakabayashi, I., Sakiyama, N. & Hishida, S. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 21, 1039-1043 (1990).
37. Mayhan, W. G., Faraci, F. M., Baumbach, G. L. & Heistad, D. D. Effects of aging on responses of cerebral arterioles. Am. J. Physiol. H1138-1143 (1990).
38. Johnson, K. A. et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50, 1563-1571 (1998).
39. Sano, M. et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336, 1216-1222 (1997).
40. Scott, M. R., Kohler, R., Foster, D. & Prusiner, S. B. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci. 1, 986-997 (1992).
41. Harris, E. D. Copper as a cofactor and regulator of copper, zinc superoxide dismutase. J. Nutr. 122, 636-640 (1992).
42. Multhaup, G. et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409 (1996).
43. Nebot, C. et al. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal. Biochem. 214, 442-451 (1993).
44. Iadecola, C. & Reis, D. J. Continuous monitoring of cerebrocortical blood flow during stimulation of the cerebellar fastigial nucleus: A study by laser-doppler flowmetry. J. Cereb. Blood Flow Metab. 10, 608-617 (1990).
45. Zhang, F., Slungaard, A., Vercellotti, G. M. & Iadecola, C. Superoxide-dependent cerebrovascular effects of homocysteine. Am. J. Physiol. 274, R1704-1711 (1998).